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CORTICOSTEROID-INDUCED DERMAL ATROPHY IN THE RAT 
JoHN M. YouNG, Ph.D., BRUCE E. YoXALL, B.S., and BoNNIE M. WAGNER, B.S. 
I nstitute of Biological Sciences , Syntex Research , Palo Alto, California. U.S.A . 
Corticosteroid-induced dermal atrophy has been studied in the rat using daily application 
of ethanolic solutions to small areas of flank skin. After 12 days of treatment, the degree of 
atrophy was determined by comparing the weights of skin plugs (16 mm diameter) taken 
from the treated areas with contralaterally paired control areas. Doses can be adjusted so 
that systemic effects are minimized and only local effects are observed. Hydrocortisone, 
hydrocortisone butyrate, dexamethasone, betamethasone, desonide and triamcinolone ace-
tonide all produce atrophy in the rat, and the degree of thinning is dose dependent. 
Potencies in the dermal atrophy assay compare directly with topical anti-inflammatory 
potencies in the rat, and the presence of fluorine in the steroid molecule is not a 
determining factor in the production of atrophy. 
Corticosteroid-induced dermal atrophy is well 
recognized as a potential consequence of prolonged 
topical use of potent corticosteroids. Although the 
original description of the phenomenon by Epstein 
et al [1], appeared in 1963, experimental investi-
gations in this area were not forthcoming until 
recently. Because the clinical atrophy effect was 
observed primarily with the more potent synthetic 
steroids. it became associated with the presence 
of fluorine in the molecule [2,3] with the resulting 
implication that nonhalogenated corticosteroids 
would not cause atrophy [3-5]. However, Castor 
and Baker f6) had shown as early as 1950 that 
topical application of hydrocortisone to the skin of 
rats caused dermal thinning. Recent publications 
[5,7-13] indicate the development of an experi-
mental approach to the problem and the need for 
methodology appropriate to quantification of der-
mal atrophy effects. 
We have examined the dermal atrophy potential 
of a series of halogenated and nonhalogenated 
corticosteroids in the rat. In this paper we describe 
the advantage and limitations of a model system 
in which atrophogenicity can be quantified on the 
basis of dose-response relationships, and the rela-
tive potencies of atrophogenic steroids can be 
evaluated. 
MATERlALS AND METHODS 
Male albino rats <Sprague-Dawley derived, Simon-
sen Labs) weighing 170 ±: 10 gm were lightly anesthe-
tized with ether, shaved on the back and flanks with 
electric clippers, and for each rat, 6 bilaterally paired 
sites, 3 on each flank, were marked by intradermal 
injection of India ink. The areas on the left flank 
served as solvent-treated controls and received 10 ~-t-1 of 
ethanol daily; the paired areas on the right flank 
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received 10 ~-t-1 of the appropriate concentration of test 
steroid in ethanol. Solvent and solutions were applied 
on days 1-5 and 8-11 with reshaving as necessary. 
Three animals , caged together without restraint. were 
used for each concentration of steroid. and individual 
body weights were determined on days 1, 5, 8, and 12. 
On day 12. twenty-four hours after the final applica-
tions, the animals were killed and the full-thkkness 
skin from the shaved area was removed. The skin was 
spread uniformly without stretching over a thin layer 
of water on a Teflon board. and 16-mm diameter circles 
centered over each tatoo mark were punched out. Each 
plug was freed from adherent fat and muscle by scrap-
ing with a dull scalpel. The plugs were blotted on 
lightly moistened filter paper and weighed to the near-
est miligram. In some cases further treatment consisted 
of - (] ) drying to constant weight at 1 oo·c a nd re-
weighing, (21 processing appropriate t o various histo-
logical procedures , or (3) preparing for the chemical 
analyses described below. 
For chemical analyses, the plugs were dried at 10o•c 
for 16 hours and broken into roughly equal pieces, 
each of which was weighed. Hexosamine was assayed 
by hydrolyzing the sample in 5 ml of 4 N HCI at 1oo•c 
for 17 hours in tightly capped tubes. After the tubes 
had cooled, 20 mg of powdered charcoal were added to 
each, and after 10 minutes the mixtures were filtered. 
Duplicate 1-ml aliquots were then assayed for hexosa-
mine according to the method of Boas f 14]. For hydrox-
yproline analysis, the samples were hydrolyzed in 3 ml 
of 6 N H Cl at 125•c for 16-18 hours. evaporated to 
dryness and redissolved in 3 ml water. The samples 
were treated with charcoal (20 mgJ. filtered, and ali-
quots of the filtrate were diluted for analysis of hydrox-
yproline content according to the method of Woessner 
f15). 
Hydrocortisone (1113.17a,21-trihydroxy-4-pregnene-
3,20-dione) was obtained from Steraloids; betametha-
sone (9cx-fluoro-1113 ,17 ex , 21- trihydroxy-1613- methyl-
pregna-1,4-diene-3,20-dioneJ and dexamethasone (9cx-
fluoro-1113,17 cx,21-trihydroxy-16cx-methylpregna-1 ,4-
diene-3,20-dione) from Schering Research; triamcino-
lone acetonide (9cx-fluor-1113,16cx,17 cx,21-tetrahydroxy-
pregna-1,4-diene,3,20-dione cyclic 16,17-acetal with 
acetone) from Sigma. Hydrocortisone butyrate (1113. 
17 a ,21-trihydroxy-4-pregnene-3,20-dione 17-butyrate), 
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prednisolone ( 11{3,17 a ,21-trihydroxypregna-1 ,4-diene-
3,20-dione) a nd desonide Cllf3,16a,l7c.t,21-tetrahydrox-
ypregna-1,4-diene-3,2Q..dione cyclic 16,17-acetal with 
acetone) were synthesized at Syntex Research . 
RESULTS 
Skin thickness in the rat is markedly dependent 
on the phase of the hair growth cycle 16,16], and 
corticosteroids are known to inhibit the initiation 
but not the continuation of new hair growth 117]. 
Therefore, consideration was given to selecting 
rats in which one growth wave was well-estab-
lished and the next would not begin within the 
experimental period. Rats of approximately 170 
gm were selected; the maximum in plug weights 
at approximately 41 days tFig 1) represents t.he 
onset of catagen of the second growth wave, when 
mitotic activity in the hair bulb ceases. Over the 
next several days, the hair continues to erupt as 
the base of the hai r shaft moves upwards in the 
dermis to assume its final resting position just 
below the base of the sebaceous gland. Reshaving 
on one or two occasions is necessary only during 
the first week of treatment. The catagen phase of 
hair growth , which begins at 18 days for the first 
growth wave and at 41 days for the secon~ . is 
associated with a slight thinning of the derffils as 
reflected by the decrease in plug weights. Animals 
of this size have a consistently large and reproduc-
ible weight gain in spite of daily handling, and 
any dimunition of the expected gain serves a. a 
sensitive indicator of systemic effects resulting 
from percutaneous absorption. 
In tht• initial experiments we decided not LOuse 
restraints, occlusion or protective dressings be-
cause of t.he extra work involved and the stressful 
effects on the animals. Instead. each ani mal 
served as its own control (each treated plug com-
pared with its contralateral control withi~ the 
same animal) so that, even though the anunals 
migh t ingest some of the solvent deposited mate-
ria] during grooming. a s trictly local effect would 
still be apparent. Ingestion of the solvent depos-
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Ftc 1. Body weight and skin plug weight in male 
albino rats (Simonsen, Sprague-Dawley den vedl. For 
each point on the plug weight curve. groups of 6 
animals were used and three 16-mm plugs were ob-
tained from each flank as described_ in "Mater~al~ and 
Methods." The vertical arrows ind1cate the hm1ts of 
the treatment period. 
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ited material is judged not to be a problem since 
only microgram quantities of steroid are applied, 
and at the end of the treatment period, particu-
larly with the higher concentrations of the more 
potent steroids, the three treated areas appear 
grossly as very circumscribed (1.5-2.0 em diame-
ter) white areas obviously thinner than the sur-
rounding normal skin . 
The data for some representative corticosteroids 
are shown in Table I. Substantial differences in 
weight exist for the three plugs taken from the 
same Dank; however. in control animals, there is 
little difference in weight between plugs taken 
from the same areas on opposite flanks. Repre-
sentative weights of plugs for a control animal 
are: 270, 275; 278, 271; 224, 221 mg ()eft and right 
flank; shoulder , midflank and pelvic region , re-
spectively). Since this normal variation would 
mask small dermal atrophy effects if the three 
plugs from each side were averaged before compar-
ing treated with control plugs. each treated plug 
is compared with its contralateral control and the 
decrease in weight for that plug is expressed as a 
percent of the control plug weight_ (last colum~. 
Table I). The repeat experiments with hydrocorti-
sone and triamcinolone acetonide show that the 
percent differences are reproducible. even though 
the absolute weights of control and treated plugs 
may show substantial variation. . 
Body weight gains are included here as a mom-
tor of absorption and systemic effects. Betametha-
sone and dexamethasone show such systemic ef-
fects at the highest dose levels. whereas hydrocor-
tisone does not. Triamcinolone acetonide a t the 
0.03'k (9 p.g per day) level also showed systemic 
effects tTable IV). One consequence of this sys-
temic effect is a general thinning of the skin over 
the whole body. so that the control plug weights 
a re lower than expected. Nevertheless. a local 
effect is still discernible. 
Plots of percent decrease in treated plug weight 
versus the log percent concentration of the test 
compounds \Fig 2l are linear and parallel for most 
compounds tested. For each compound , the best 
straight line was fitted to the data by the method 
of least squares, and potencies relative to hydro-
cortisone were calculated using the exact method 
of Finney 118). 
It was of interest to compare the dermal atrophy 
potencies of these compounds \\<ith some measure 
of topical anti-inflammatory activity in the sam_e 
species. and data obtained from the croto~-01l 
induced infl ammation in the rat ear as descnbed 
by Tonelli . Thibault, and Ringer 119] ap~eared 
suitable. In this latter assay, a l lk solutiOn of 
croton oil in eth er-water-pyridine (15:1:4) alone or 
with the appropriate concentration of steroid, is 
applied to one ear of 21- day-old rats. After 6 
hours the treated ears are removed. uniform 
plugs' are punched out, and the plugs. weig~ed~ 
Plugs from inflamed ears show substa~~1al we1ght 
increases relative to controls, and anti-Inflamma-
tory corticosteroids inhibit this weight increase in 
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TABLE I. Body weight gains and skin plug weights for some representatiue corticosteroids 
Daily dose Tissue weights, mg• 
Body weight gain, 
% J.Lg gm" Control Treated % Paired differences' 
Hydrocortisone # 1 
1.0 300 69 ::!: 2 288 ::!: 30 203 ::!: 20 - 29.3 ± 6.1 
0.3 90 76::!: 13 270 ± 22 218 ± 18 - 19.3::!: 4.4 
0.1 30 75 ::!: 8 281 :t 29 254 :t 33 - 9.7 :t 4.8 
Hydrocortisone # 2 
1.0 300 64 ::!: 14 173 :t 38 116 ± 27 -32.5 :t 9.1 
0.3 90 75::!: 5 195 ::!: 29 155 :t 19 - 20.2 ::!: 7.5 
0.03 9 97::!: 4 218 ± 36 213 ± 36 -2.1 ± 5.5 
Betamethasone 
0.1 30 44 :t 12 214 ::!: 25 157 :!: 23 -26.3 ::!: 9.9 
0.03 9 70 ± 7 230 ± 26 177 :!: 19 - 22.7 :!: 7.9 
0.01 3 71 := 7 241 :!: 25 210 ± 26 - 17.8:!: 8.1 
Dexamethasone 
0.03 9 45 ::!: 4 194 :t 21 151 :!: 23 - 22.3:!: 7.2 
0.01 3 88 ::!: 11 241 ± 28 203 :!: 23 - 15.6 ± 5.4 
0.003 0.9 71::!: 23 227 ± 19 219 :!: 29 -3.7 :t 5.3 
Triamcinolone acetonide #] 
0.01 3 75::!: 14 215 :!: 31 151 :!: 31 -30.2 :!: 6.2 
0.003 0.9 86 ::!: 11 251 ::!: 21 197 :!: 21 - 21.3 ::!: 6.2 
0.001 0.3 92 ::!: 7 261 ::!: 28 231 :!: 22 -11.2 :z: 6.4 
Triamcinolone acetonide #2 
0.01 3 78 ± 10 261 :!: 23 172 ::: 16 -33.9:!: 5.8 
0.003 0.9 78:!: 11 270 ::!: 20 204:!: 23 -24.3 :!: 7.4 
0.001 0.3 76 :±: 13 239 ± 24 212 :t 24 - 11.2 ::!: 3.5 
" Average of3 rats for each concentration (± SDJ. 
b Average of3 plugs from each of the 3 rats (:!: SDJ. 
,. Difference between each treated and control pair expressed as a percent of the control plug weight c:!: SDJ. 
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FtG 2. Plot of percent decrease in treated plug 
weight compared with control plug weight against the 
percent concentration of the steroid in etha nol. Each 
point represents the average of 3 treated plugs from 
each of three rats, and the best straight line was 
determined by the method of least squares. 
a dose-responsP manner. In spite of the obvious 
differences between the two assays, particularly 
with respect to time. application si te and solvents, 
the correspondence is remarkably good. A pJot of 
the relative potencies <hydrocortisone = 1 l in the 
two assays is shown in Figure 3. The correlation 
coefficient calculated from the data in Table I1 is 
0.99 (with a slope of 1.06 and intercept of 6.26). 
indicating a very high degree of correlation be-
tween activities in the two assays for these com-
pounds. 
Skin plugs from rats treated with 0.01 %: triam-
cinolone acetonide were subjected to further anal-
ysis in order to confirm the histological finding 
that protein loss had indeed occurred. On drying 
to constant weight, the treated plugs still showed 
a significant weight loss (Table ill) which was 
reflected in decreased hexosamine and hydroxy-
proline contents of the plugs. The treated plugs 
had a slightly lower water content (65%) than the 
control plugs (69%), but this was to be expected 
since collagen (hydroxyproline) and mucopolysac-
charide (hexosamine) are highly hydrated relative 
to keratin and other proteins. 
Not~ . 1977 
In order to investigate the reversibility of the 
atrophy process, groups of animals were treated 
with 0.03~ triamcinolone acetonide on days 1-5 
and 8-11 as usual. One group was sacrificed on 
day 12, and the remaining groups without further 
treatment were sacrificed at weekly intervals 
thereafter. From the results presented in Table 
IV it can be seen that the corticosteroid-treated 
skin returns Lo normal weight by three weeks 
after cessation of treatment. The abrupt thicken-
ing of the atrophied areas between days 26 and 33 
is not easily explained, but is probably related to 
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Frc 3. Correlation between anti-inflammatory po-
tency and dermal atrophy for \'arious steroids in the 
rat. In each assay the potencies were determined rela-
tive to hydrocortisone= l. 
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skin thickening in response to the third hair 
growth cycle (Fig 1). 
DISCUSSION 
As originally shown by Castor and Baker [6], it 
is possible to induce atrophic changes in dermis of 
rats by topical application of adrenocortical ste-
roids. In addition to the obvious histological 
changes. our studies show that the atrophy is 
associated with a decrease in both collagen and 
mucopolysaccharide, and is not simply a vasocon-
strictive-like effect leading to decreases in fluid 
content of the tissues. Furthermore, since each 
animal serves as its own control, it is clear that 
the atrophy is a strictly local effect and is re-
TABLE II. Dermal atrophy and anti-inflammatory" 
potencies of corticosteroids in the rat relative to 
hydrocortisone 
Corticosteroid Dermal atrophy Anti-i nflamma-tory'' 
Hydrocortisone 1 I 
Prednisolone 4 !2.4-6.2)1' 3 
Hydrocortisone 17-bu- 7 (4.4-9.21 13 
tyrate 
Betamethasone 13-16' 25 
Dexamethasone 16 !10-23) 30 
Desonide 52 {32-82) 70 
Triamcinolone ace to- 121 (91-1641 130 
nide 
" Anti-inflammatory activities were determined us-
ing the croton oil-induced ear edema method of Tonelli , 
Thibault, and Ringer [19). Data on file at Syntex 
Research. 
" 95'1( Fiduciallimtis. 
• Graphical estimate only. 
TAB I.E Ill. Analytical results of skin plugs from a group of 3 rals treated with 0.01 'k triamcinolone acetonide 
Control Treated .l .l 'k 
Plug weight. mg wet 261 :::: 23" 172 :!: 16" - 89:!: 20b -33.9 ± 5.8b 
Plug weight. mg dry 82 :::: 9 59± 5 - 23 ± 7 -27.4 ± 6.2 
Water content, mg/plug 180 :::: 16 112 ± 14 - 67 ± 15 -37.3 ± 6.9 
Hexosamine, ~-tgiplug 372 ::: 51 256 ± 12 - 116 ± 48 - 30.3 ± 8.2 
Hydroxyproline. mg/plug 4.7 :::: 0.9 3.6 ± 0.4 - 1.1 ± 0.8 - 22.0 ± 12.4 
" Average of 3 plugs from each of 3 rats ( ± SDl. 
" Average of the differences between each treated plug and its respective control plug (z: SDl. All values are 
s ignificant at the p< O.OOl level. 
TABLE IV. Rebound of treated pi ug weights after cessation of steroid application 
Groups of rats treated with 0.03 'k triamcinolone acetonide on days 1-5 and 8-11 were sacrificed at weekly 
intervals following t he last steroid application. 
Tissue weights, mg 
Days from last 
Body weight gain, gm" Control treatment 
) 57± 91' 234 ± 21' 
8 100 :: 13 273 = 31 
15 146 ::: JO 338 :: 37 
22 186 :: 16 343 = 41 
" Relative to weights on first day of treatment (180 ::: 2 gm). 
'' Average of 4 rats (± SDl. 
' Average of3 plugs from each of4 rats (::t SDl. 
Treated 
158 ± 17C 
187 ± 23 
264 = 32 
349 ± 51 
91' Decrease 
- 32.3 ± 5.!P 
-31.6 ± 5.0 
- 21.7±4.5 
+ 1.9:::9.2 
'
1 Difference between each treated and control pair e>..'Jlressed as a percent of the control plug weight ( ± SDl. 
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stricted to the site of application. Kirby and 
Munro 110] have studied the effect of commercial 
formulations on the thickness of mouse ear skin 
by treating one ear with steroid and the other 
with ointment base. However, both ears decreased 
in thickness in parallel, indicating a syst emic 
effect. Similarly. a study involving commercial 
formulations in rats [121 also resulted in substan-
tial systemic effects as evidenced by reduced 
weight gains for all compounds except hydrocorti-
sone. In both these studies it is impossible to 
discriminate between truly local efJects and gen-
eral systemic impairment of metabolism. 
With respect t o the effect of halogen substitution 
in the steroid molecule. our studies show that it is 
not the determining factor in dermal atrophy. 
Hydrocortisone. hydroc01-tisone butyrate. and de-
sonide all produce dermal atrophy to a degree 
entirely consistent with their antiinflammatory 
activities. In a study involving both mouse and 
human (10], hydrocortisone and its butyrate pro-
duced atrophy in both species, and in the human 
hydrocortisone butyrate produced the greatest de-
gree of skin thinning of all compounds tested. 
For the limited number of compounds tested. 
dermal atrophy potency correlates very well with 
anti-inflammatory activity. but it is hoped that 
further testing will lead to the identification of 
compounds which show desirable separations of 
activity in the two assays. Since ethical consider-
ations preclude extensive screening for derma l 
atrophy in humans, an animal model must be 
used, and this rat assay serves well since it gives 
a rapid and sensitive response which can be quan-
titated gravimetrically. Furthermore, anti-in-
flammatory and dermal atrophy assays ar e carried 
out in the same species. so that separations of 
activity are readily detectable. 
One note of caution -it must be remembered 
that anti-inflammatory activities of steroids differ 
in the rat and in the human 1201. and it is to be 
expected that relative dermal atrophy potencies 
wouJd also change between species. In addition. 
these studies were carried out ..... ;th solvent depos-
ited steroids. whereas in practice the steroids are 
formulated. some optimally and some poorly. 
Therefore, it would be dangerous to extrapolate 
relative rat dermal atrophy potency directly to 
the human without taking into account any differ-
ences in anti-inflammatory potency. 
The rat ear anti-inflammatory data were generated 
in the Bioassay Department. Syntex Institute of Biolog-
ical Sciences, under the direction of Mr. Wendell Rooks 
to whom we are indebted. 
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